Market Overview

Recap: ChromaDex Q4 Earnings


ChromaDex (NASDAQ:CDXC) reported Q4 results.

Quarterly Results

• Earnings came in at a loss of $0.11 per share, in line with the estimate.

• Revenue of $13,089,000 higher by 44.36% from the same period last year, which beat the estimate of $12,910,000.

Looking Ahead

• Q1 revenue expected between $5,600,000 and $5,600,000.

How To Listen To The Conference Call

• Date: Mar 10, 2020

• Time: 09:00 PM ET

Webcast URL

Price Action

• 52-week high was at $4.95

• 52-week low: $2.68

• Price action over last quarter: Up 13.58%

Company Description

ChromaDex Corp is a science-based integrated nutraceutical company. The products of the company are devoted at improving human immune function. The company produces dietary supplements, skin care, pharmaceutics, and animal health products.


Related Articles (CDXC)

View Comments and Join the Discussion!

Posted-In: Earnings News After-Hours Center